Wafik El-Deiry, Director of Legorreta Cancer Center at Brown University and Chair of the WIN Consortium in Cancer Personalized Medicine, shared on LinkedIn:
“The WIN Consortium in cancer personalized medicine Molecular Tumor Board discussed a case of diffuse hemispheric glioma with H3G34R mutation at the recent WIN Symposium in Rhode Island on October 2nd, 2026.
Great discussion by the assembled leaders in precision oncology and great audience questions as well.